Literature DB >> 12354318

Cued recall in early-stage dementia in adults with Down's syndrome.

D A Devenny1, E J Zimmerli, P Kittler, S J Krinsky-McHale.   

Abstract

BACKGROUND: Memory declines were evaluated with an adaptation of the Cued Recall Test (CRT) in 19 adults with Down's syndrome (DS) with mild or moderate intellectual disability (ID) who were at an early-stage of dementia of the Alzheimer type (DAT), and their performance was compared to peer groups of 75 adults with DS and 66 adults with ID without DS who were not suspected of functional declines.
METHOD: The CRT consisted of a training period in which 12 items were presented, four at a time, with each item accompanied by a unique category cue. The testing phase consisted of three trials which generated two measures, a free recall score (FRS; spontaneous recall of the list of 12 items) and a total score (TS; FRS plus items recalled when the category cue was provided).
RESULTS: It was found that a cut-off value of < or = 23 on the TS resulted in a sensitivity of 94.7% and a specificity of 93.9% with a positive predictive value of 81.9% when those individuals with DAT were compared to the participants with ID without DS. Eight of these individuals with DAT had relatively poor performance on the CRT compared to their healthy peers at a baseline when they were not suspected of functional declines, suggesting that memory declines can occur several years prior to the identification of DAT. In addition, 17 participants with DS without a diagnosis of DAT met the criterion for the cut-off score. Longitudinal data and converging measures indicated that there was the possibility that 15 of these individuals are in a 'pre-clinical' stage of decline.
CONCLUSION: The usefulness of the CRT as a screening test for early memory deficits for this population needs to be confirmed by following these participants for an extended period of time and by studying an independent sample.

Entities:  

Mesh:

Year:  2002        PMID: 12354318     DOI: 10.1046/j.1365-2788.2002.00417.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  19 in total

1.  Alzheimer's Disease in Adults with Down Syndrome.

Authors:  Warren B Zigman; Darlynne A Devenny; Sharon J Krinsky-McHale; Edmund C Jenkins; Tiina K Urv; Jerzy Wegiel; Nicole Schupf; Wayne Silverman
Journal:  Int Rev Res Ment Retard       Date:  2008-01-01

2.  Identifying dementia in Down syndrome with the Severe Impairment Battery, Brief Praxis Test and Dementia Scale for People with Learning Disabilities.

Authors:  E R Wallace; J P Harp; K L Van Pelt; L M Koehl; A M Caban-Holt; A J Anderson-Mooney; G A Jicha; D D Lightner; W C Robertson; E Head; F A Schmitt
Journal:  J Intellect Disabil Res       Date:  2021-11-16

Review 3.  Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches.

Authors:  Clíona Farrell; Paige Mumford; Frances K Wiseman
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

4.  A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials.

Authors:  Susana de Sola; Rafael de la Torre; Gonzalo Sánchez-Benavides; Bessy Benejam; Aida Cuenca-Royo; Laura Del Hoyo; Joan Rodríguez; Silvina Catuara-Solarz; Judit Sanchez-Gutierrez; Ivan Dueñas-Espin; Gimena Hernandez; Jordi Peña-Casanova; Klaus Langohr; Sebastia Videla; Henry Blehaut; Magi Farre; Mara Dierssen
Journal:  Front Psychol       Date:  2015-06-04

Review 5.  Cognitive Rehabilitation of Dementia in Adults with Down Syndrome: A Review of Non-Pharmacological Interventions.

Authors:  Luciana Mascarenhas Fonseca; Anna Carolina Rufino Navatta; Cássio M C Bottino; Eliane Correa Miotto
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-09-18

Review 6.  A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.

Authors:  Frances K Wiseman; Tamara Al-Janabi; John Hardy; Annette Karmiloff-Smith; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher; André Strydom
Journal:  Nat Rev Neurosci       Date:  2015-08-05       Impact factor: 34.870

7.  Alzheimer-related altered white matter microstructural integrity in Down syndrome: A model for sporadic AD?

Authors:  H Diana Rosas; Eugene Hsu; Nathaniel D Mercaldo; Florence Lai; Margaret Pulsifer; David Keator; Adam M Brickman; Julie Price; Michael Yassa; Christy Hom; Sharon J Krinsky-McHale; Wayne Silverman; Ira Lott; Nicole Schupf
Journal:  Alzheimers Dement (Amst)       Date:  2020-11-07

Review 8.  Dissecting Alzheimer disease in Down syndrome using mouse models.

Authors:  Xun Yu Choong; Justin L Tosh; Laura J Pulford; Elizabeth M C Fisher
Journal:  Front Behav Neurosci       Date:  2015-10-13       Impact factor: 3.558

Review 9.  A critical literature review of the effectiveness of various instruments in the diagnosis of dementia in adults with intellectual disabilities.

Authors:  Jordan Elliott-King; Sarah Shaw; Stephan Bandelow; Rajal Devshi; Shelina Kassam; Eef Hogervorst
Journal:  Alzheimers Dement (Amst)       Date:  2016-06-30

10.  VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome.

Authors:  Alberto Lleó; Maria Carmona-Iragui; Laura Videla; Susana Fernández; Bessy Benejam; Jordi Pegueroles; Isabel Barroeta; Miren Altuna; Silvia Valldeneu; Mei-Fang Xiao; Desheng Xu; Raúl Núñez-Llaves; Marta Querol-Vilaseca; Sònia Sirisi; Alexandre Bejanin; M Florencia Iulita; Jordi Clarimón; Rafael Blesa; Paul Worley; Daniel Alcolea; Juan Fortea; Olivia Belbin
Journal:  Alzheimers Res Ther       Date:  2021-06-28       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.